SCHEMBL5925877

SCHEMBL5925877

COc1ccc(I)c(S)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NNMT P40261 2/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
CYP1A2 P05177 1/20 0.35
KMT2A Q03164 1/20 0.35
CLK1 P49759 2/20 0.33
DYRK1A Q13627 2/20 0.33
CLK2 P49760 1/20 0.33
CLK3 P49761 1/20 0.33
CDK5 Q00535 1/20 0.33
CDK5R1 Q15078 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
MTNR1A P48039 3/20 0.33
MTNR1B P49286 3/20 0.33
PDE10A Q9Y233 1/20 0.32
HTR2C P28335 2/20 0.31
HTR2A P28223 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18774086 0.76 NNMT (0.48) POLBTDP1NNMTSIRT2SIRT1
SCHEMBL5839510 0.76 POLB (0.50) POLBTDP1NNMTSIRT2SIRT1
SCHEMBL5925796 0.74 NNMT (0.39) POLBTDP1NNMTSIRT2SIRT1
SCHEMBL22564747 0.74 HPGD (0.38) POLBTDP1NNMTSIRT2SIRT1
SCHEMBL22953996 0.74 HTT (0.37) POLBTDP1NNMTSIRT2SIRT1
SCHEMBL12677821 0.74 CYP1A2 (0.39) POLBTDP1NNMTSIRT2SIRT1
SCHEMBL3751660 0.74 NNMT (0.39) POLBTDP1NNMTSIRT2SIRT1
SCHEMBL2461286 0.74 POLB (0.36) POLBTDP1NNMTSIRT2SIRT1
SCHEMBL5391265 0.69 TSHR (0.39) PDE10AKDM4E
SCHEMBL16511925 0.69 MTNR1A (0.44) POLBTDP1NNMTSIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060183758-A1 Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans CB RESEARCH AND DEVELOPMENT, INC. (US) 2006-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183758-A1 Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans TPMT, INMT, AANAT POLB 3108/4885TDP1 626/4885NNMT 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.